0000912282-15-000099.txt : 20150319 0000912282-15-000099.hdr.sgml : 20150319 20150318183641 ACCESSION NUMBER: 0000912282-15-000099 CONFORMED SUBMISSION TYPE: 8-K PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20150318 ITEM INFORMATION: Regulation FD Disclosure FILED AS OF DATE: 20150319 DATE AS OF CHANGE: 20150318 FILER: COMPANY DATA: COMPANY CONFORMED NAME: Great Basin Scientific, Inc. CENTRAL INDEX KEY: 0001512138 STANDARD INDUSTRIAL CLASSIFICATION: SURGICAL & MEDICAL INSTRUMENTS & APPARATUS [3841] IRS NUMBER: 830361454 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 FILING VALUES: FORM TYPE: 8-K SEC ACT: 1934 Act SEC FILE NUMBER: 001-36662 FILM NUMBER: 15711262 BUSINESS ADDRESS: STREET 1: 2441 SOUTH 3850 WEST STREET 2: SUITE #A-200 CITY: WEST VALLEY CITY STATE: UT ZIP: 84119 BUSINESS PHONE: (801) 990-1055 MAIL ADDRESS: STREET 1: 2441 SOUTH 3850 WEST STREET 2: SUITE #A-200 CITY: WEST VALLEY CITY STATE: UT ZIP: 84119 8-K 1 gbasin8k_031815.htm gbasin8k_031815.htm
 

UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

FORM 8-K

CURRENT REPORT

Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934

Date of Report (Date of earliest event reported):  March 18, 2015

 
GREAT BASIN SCIENTIFIC, INC.
(Exact name of registrant as specified in its charter)
         
Delaware
  
001-36662
  
83-0361454
(State or other jurisdiction of incorporation)
  
Commission
File Number)
  
(IRS Employer
Identification No.)
         
2441 South 3850 West, Salt Lake City, UT
(Address of principal executive offices)
 
84120
(Zip code)
 
(801) 990-1055
(Registrant’s telephone number, including area code)
 
N/A
(Former name or former address, if changed since last report.)

Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions (see General Instruction A.2 below):

[   ]
Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425)
   
[   ]
Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)
   
[   ]
Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b))
   
[   ]
Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c))

1
 
 
 

Item 7.01 Regulation FD Disclosure.
On March 18, 2015, Great Basin Scientific, Inc. (the “Company”) held an investor update call to provide investors with additional information on the Company’s progress. A webcast of the call is available on the investor relations section of the Company’s website at www.gbscience.com, and a transcript of the call will be posted to the Company’s website when it is available.
 
The information in this Current Report shall not be deemed “filed” for purposes of Section 18 of the Securities Exchange Act of 1934, as amended, nor shall it be deemed incorporated by reference into any filing under the Securities Act of 1933, as amended, except as shall be expressly set forth by specific reference in such filing.
 

2
 
 
 


SIGNATURE
 
Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.

 
     GREAT BASIN SCIENTIFIC, INC.
   
   
Date: March 18, 2015
By:
/s/ Ryan Ashton                                         
   
Ryan Ashton
   
President and Chief Executive Officer

3